What they were paid
TEVA PHARMACEUTICAL INDUSTRIES Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $125,000 | $249,987 | $0 | $0 | $374,987 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: TEVA PHARMACEUTICAL INDUSTRIES LTD DEF 14A filed March 31, 2026, accession 0001193125-26-134756, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025TEVA PHARMACEUTICAL INDUSTRIES pays directors a $100,000 cash retainer and $250,000 in RSUs.
Committees
FY2025 · as the proxy prints themFinance and Investment · Science and Technology
The rest of the TEVA PHARMACEUTICAL INDUSTRIES board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Amir Elstein | Independent Director | $392,487 |
| Chen Lichtenstein | Independent Director | $382,487 |
| Dr. Perry D. Nisen | Independent Director | $394,987 |
| Dr. Sol J. Barer | Chair of the Board | $599,998 |
| Gerald M. Lieberman | Independent Director | $414,987 |
| Janet S. Vergis | Independent Director | $394,987 |
| Prof. Ronit Satchi-Fainaro | Independent Director | $379,987 |
| Prof. Varda Shalev | Independent Director | $369,987 |
| Richard D. Francis | Director | $0 |
| Roberto A. Mignone | Independent Director | $399,987 |
| Rosemary A. Crane | Independent Director | $389,987 |
The full TEVA PHARMACEUTICAL INDUSTRIES compensation record
free company briefThis page is one director within TEVA PHARMACEUTICAL INDUSTRIES's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat